Guide To Digital Endpoints In Oncology Research

There is broad use of digital endpoints in cancer clinical trials. With wrist-worn wearables able to examine physical activity, circadian rhythm, and sleep, the technology opens up novel endpoints that provide insights into patient-centric outcomes that were once impossible to capture.^1,2 With the FDA’s support of patient focused drug development, including the use of digital endpoints in assessing activity in performance-based outcome measures,^3,4 companies that generate such insights stand to differentiate their products through real-time digital data.